Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TESAMORELIN for Lipodystrophy acquired: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,255 adverse event reports in the FDA FAERS database where TESAMORELIN was used for Lipodystrophy acquired.

Most Reported Side Effects for TESAMORELIN

Side Effect Reports % Deaths Hosp.
Product dose omission issue 277 11.5% 0 13
Arthralgia 188 7.8% 1 4
Injection site pain 186 7.7% 1 5
Incorrect dose administered 167 6.9% 0 2
Drug ineffective 159 6.6% 0 7
Weight increased 138 5.7% 0 5
Injection site bruising 134 5.6% 1 2
Peripheral swelling 126 5.2% 1 2
Pain in extremity 121 5.0% 0 4
Product preparation issue 119 4.9% 0 2
Injection site pruritus 117 4.9% 1 3
Hypoaesthesia 87 3.6% 0 2
Therapeutic product effect incomplete 86 3.6% 0 1
Wrong technique in product usage process 78 3.2% 1 1
Fatigue 77 3.2% 0 6

Other Indications for TESAMORELIN

Product used for unknown indication (320) Hiv infection (179) Lipohypertrophy (97) Non-alcoholic steatohepatitis (13) Acquired immunodeficiency syndrome (5)

Other Drugs Used for Lipodystrophy acquired

METRELEPTIN (477) EGRIFTA (16) SOMATROPIN (15)

Related Pages

TESAMORELIN Full Profile All Lipodystrophy acquired Drugs TESAMORELIN Demographics TESAMORELIN Timeline